Kinsale Capital Group Inc

Explore Kinsale Capital’s insider moves: CEO and C‑A&T officer balance buying and selling while the stock sits below its 52‑week high, hinting at a bullish outlook on long‑term growth.

Kehoe’s May 5, 2026 trades reveal a sophisticated Rule 10b‑5 strategy: buying at $16, selling 48k shares near $302, and exercising options, balancing insider confidence with tax‑smart liquidity while awaiting Kinsale’s earnings and governance shifts.

Explore Kinsale Capital’s insider round‑trip trades—zero‑cost shares, no market impact, and tax‑efficient strategies—revealing executive confidence and long‑term value.

Insightful Kinsale Capital insider moves: CEO holds shares, opts for future gains, hinting at rebound potential and strategic growth in specialty insurance.

Insider buying at Kinsale Capital signals confidence and a strategic shift into high‑margin pharma supply‑chain insurance, with a valuation below the S&P 500 and solid liquidity management.

Insightful insider activity at Kinsale Capital Group shows long‑term confidence, yet no impact on growth or risk strategy—stay informed about the firm’s stable specialty‑insurance outlook.